Narayanam Mallikarjun, Sahu Archana, Singh Saranjit
Biocon-BMS R&D Centre (BBRC), Biocon Park, Bangalore, India.
Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar 160 062, Punjab, India.
J Pharm Biomed Anal. 2015;111:190-203. doi: 10.1016/j.jpba.2015.03.038. Epub 2015 Apr 3.
Forced degradation studies on cilazapril were carried out according to ICH and WHO guidelines. Significant degradation of the drug was observed in acid and base conditions, resulting primarily in cilazaprilat. In neutral condition, five degradation products were formed, while under oxidative condition, two degradation products were generated. In total, seven degradation products were formed, which were separated on an Inertsil C-18 column using a stability-indicating HPLC method. Structure elucidation of the degradation products was done by using sophisticated and hyphenated tools like, LC-MS/TOF, LC-MS(n), on-line H/D exchange, LC-NMR and NMR. Initially, comprehensive mass fragmentation pathway of the drug was laid down. Critical comparison of mass fragmentation pathways of the drug and its hydrolytic degradation products allowed structure characterization of the latter. 1D and 2D proton LC-NMR studies further confirmed the proposed structures of hydrolytic degradation products. The oxidative degradation products could not be characterized using LC-MS and LC-NMR tools. Hence, these degradation products were isolated using preparative HPLC and extensive 1D ((1)H, (13)C, DEPT) and 2D (COSY, TOCSY, HETCOR and HMBC) NMR studies were performed to ascertain their structures. Finally, degradation pathways and mechanisms of degradation of the drug were outlined.
根据国际协调会议(ICH)和世界卫生组织(WHO)的指导方针,对西拉普利进行了强制降解研究。在酸性和碱性条件下观察到该药物有显著降解,主要生成西拉普利拉。在中性条件下,形成了5种降解产物,而在氧化条件下,生成了2种降解产物。总共形成了7种降解产物,使用稳定性指示高效液相色谱法在Inertsil C-18柱上进行分离。通过使用复杂的联用工具,如液相色谱-质谱/飞行时间(LC-MS/TOF)、液相色谱-质谱(n)(LC-MS(n))、在线氢/氘交换、液相色谱-核磁共振(LC-NMR)和核磁共振(NMR),对降解产物进行结构解析。首先,确定了该药物的全面质谱裂解途径。通过对该药物及其水解降解产物的质谱裂解途径进行关键比较,对后者进行了结构表征。一维和二维质子液相色谱-核磁共振研究进一步证实了水解降解产物的推测结构。使用液相色谱-质谱和液相色谱-核磁共振工具无法对氧化降解产物进行表征。因此,使用制备型高效液相色谱法分离这些降解产物,并进行了广泛的一维((1)H、(13)C、无畸变极化转移增强法(DEPT))和二维(同核相关谱(COSY)、全相关谱(TOCSY)、异核单量子相关谱(HETCOR)和异核多键相关谱(HMBC))核磁共振研究以确定其结构。最后,概述了该药物的降解途径和降解机制。